Blocking Interleukin-1β: A Double-Edged Sword in Experimental Atherosclerosis

Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1537-1539. doi: 10.1161/ATVBAHA.124.321113. Epub 2024 May 30.
No abstract available

Keywords: Editorials; atherosclerosis; inflammation; interleukins; myocytes, smooth muscle.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Atherosclerosis* / immunology
  • Atherosclerosis* / metabolism
  • Atherosclerosis* / pathology
  • Atherosclerosis* / prevention & control
  • Disease Models, Animal*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use
  • Interleukin-1beta* / metabolism
  • Mice
  • Plaque, Atherosclerotic
  • Signal Transduction

Substances

  • Interleukin-1beta
  • Anti-Inflammatory Agents
  • Interleukin 1 Receptor Antagonist Protein